The Morning Dispatch: Vaccine in Sight, but Trouble Ahead

Happy Monday! Three weeks from today, with the election behind us (we hope!), The Dispatch will host a two-day conference to examine the elections and their meaning. Some of the country’s top thinkers will be on hand to discuss what’s happened and what’s to come—in the nation’s capital, on the center-right, and for the country. Head over to for details and stay tuned—we’ll be announcing additional speakers over the next three weeks.

Quick Hits: Today’s Top Stories

  • The United States confirmed 49,951 new cases of COVID-19 yesterday per the Johns Hopkins University COVID-19 Dashboard, with 5.2 percent of the 962,806 tests reported coming back positive. An additional 512 deaths were attributed to the virus on Sunday, bringing the pandemic’s American death toll to 219,669.

  • Thousands attended demonstrations in France over the weekend in solidarity with Samuel Paty, a schoolteacher who was beheaded in the street by an apparent Islamic extremist on Friday.* During a lesson for his students on freedom of expression, Paty had displayed caricatures of the prophet Muhammed from Charlie Hebdo, the satirical magazine whose Paris headquarters was attacked in 2015. 

  • Pfizer CEO Dr. Albert Bourla announced on Friday the pharmaceutical giant will not apply for emergency authorization of its COVID-19 vaccine until the third week of November at the earliest. “Safety is, and will remain, our number one priority,” he wrote.

This content is available exclusively to Dispatch members
Try a membership for full access to every newsletter and all of The Dispatch. Support quality, fact-based journalism.
Already a paid member? Sign In
Comments (0)
Join The Dispatch to participate in the comments.

There are currently no responses to this article.
Be the first to respond.